Close
Nordic 9Nordic 9

Ersel (investor - Private Equity)

Italy ersel.it
See something wrong or missing? Let us know
Offices:Turin

Ersel is an asset manager from Italy.

Average round investment:13.11M USD
Average number per year:1.0
Distribution: 2022 (1)2021 (1)
Portfolio companies: Italy Kither BiotechItaly EpiCura
Mostly invests in: Italy Italy (2) Health services (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Ersel

Name Criteria
Germany L&R Ventures
89%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Norway Sparebank 1 SMN Invest
88%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
United States Lionheart Ventures
88%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Norway Canica AS
88%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
Spain Aliath Bioventures
88%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Sweden Crosslight Partners
88%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
France Nabuboto
87%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Simon Capital
87%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
France Alter Equity
87%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Norway Ferd Capital
87%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Top